Evidence map›Paper›PMID 29037606›Full record

ArticleEBioMedicine2017

Plasma HSP90α and liver cancer: a potential biomarker?

Carole Sourbier

Open access · goldAbstract readComment
In one paragraph

Article in EBioMedicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Diagnostic value of HSP90α and related markers in lung cancer.Journal of clinical laboratory analysis · 2022
    Article
  3. Article
  4. Plasma Heat Shock Protein 90 Alpha: A Valuable Predictor of Early Chemotherapy Effectiveness in Advanced Non-Small-Cell Lung Cancer.Medical science monitor : international medical journal of experimental and clinical research · 2021
    Article
  5. PKM2 is the target of proanthocyanidin B2 during the inhibition of hepatocellular carcinoma.Journal of experimental & clinical cancer research : CR · 2019
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Carole SourbierUrologic Oncology Branch, National Cancer Institute, NIH, Bldg 10, CRC 1W-3961, 9000 Rockville Pike, Bethesda, MD 20892, United States. Electronic address: sourbierc@mail.nih.gov.
National Cancer Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Biomarkers, TumorLiver NeoplasmsHSP90 Heat-Shock ProteinsHumansBiomarkers, TumorHSP90AA2P protein, humanHSP90 Heat-Shock Proteins

Identifiers

PMID29037606
PMCPMC5704057
OpenAlexW2762047467

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.